The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.

China’s BeiGene, which is developing a portfolio of immuno-oncology drugs, has struck a deal with a Chinese development agency to build a biologics plant to…

Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.

Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

It's become well-recognized that pharma companies need to move beyond the "not invented here" mindset and tap into the scientific expertise of…

Daiichi Sankyo licenses two abuse-deterrent painkillers from Inspirion to further its pain-management ambitions.

China's FDA says reports that 83% of trials have fabricated results are incorrect, but the numbers suggest the country still has a big data-integrity…

R&D